Prediction of EGFR and KRAS mutation in non-small cell lung cancer using quantitative 18F FDG-PET/CT metrics. - PubMed
ncbi.nlm.nih.gov/pubmed/28538213Posted Jun 3, 2017, 4:59 PM UTC
10
ncbi.nlm.nih.gov
Loading comments…
Posted Jun 3, 2017, 4:59 PM UTC